England Records 1,021 Daily Cancer Diagnoses in 2024
New NHS data shows a rise in early-stage detection, yet treatment targets remain unmet as service pressure grows.
By Arjun Weber ·
The National Health Service in England identified 1,021 new cancer cases every day in 2024, the highest daily average recorded to date. This figure represents a jump from the 972 daily diagnoses reported the previous year. In total, registration services logged more than 373,000 new cancer cases during the calendar year.
Prostate, breast, lung, and bowel cancers accounted for half of all new diagnoses. The data reveals a slight shift in the stage at which these conditions were detected. Fifty-six point seven percent of new cases were caught at stage 1 or 2 in 2024, up from 55.8 percent in 2023. NHS officials view this change as progress toward their goal of earlier identification.
Prof Peter Johnson, the NHS national clinical director for cancer, said the figures show the health service is moving in the right direction. He credited NHS staff for bringing tests and checks closer to patients. Johnson noted that the focus remains on getting people seen and treated as early as possible while new treatments are developed.
Despite the increase in early detection, the health service is missing its internal deadlines. In August, 78.6 percent of patients urgently referred for suspected cancer were diagnosed or had cancer ruled out within 28 days. This falls short of the 80 percent target set for the service.
The gap is wider for treatment start times. Only 71.9 percent of patients began treatment within 62 days of an urgent referral or consultant upgrade. The target for this metric is 85 percent. These numbers indicate continued pressure on cancer services to streamline care pathways.
Dr Ian Walker, executive director of policy at Cancer Research UK, warned that staff are diagnosing more people, but too many are still being caught at a late stage. He stated that the health service requires additional support to reduce late-stage diagnoses and ensure patients are treated on time. Walker called on the UK government to maintain momentum on its national cancer plan for England, citing the need for focused effort, clear accountability, and guaranteed resources for specialist staff and equipment.
Dr Hilary Williams, clinical vice-president at the Royal College of Physicians, identified an ageing population as a key factor in the rising numbers. She also pointed to obesity as a major and often overlooked risk factor. Williams stressed the need for continued improvements in early detection, including the expansion of targeted lung cancer screening.
Steven McIntosh, chief partnerships officer at Macmillan Cancer Support, said the aggregate figures mask persistent health inequalities. He explained that a person's identity and location can impact their likelihood of getting cancer, the speed of their diagnosis, and their chances of survival. Rachael Franklin, deputy chief executive of Breast Cancer Now, added that breast cancer remains the leading cause of death among working-age women in the UK, with one in seven women expected to be diagnosed in their lifetime.
